Palouse Capital Management, Inc. Incyte Corp Transaction History
Palouse Capital Management, Inc.
- $137 Million
- Q1 2025
A detailed history of Palouse Capital Management, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Palouse Capital Management, Inc. holds 18,083 shares of INCY stock, worth $1.18 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
18,083
Previous 18,882
4.23%
Holding current value
$1.18 Million
Previous $1.3 Million
16.1%
% of portfolio
0.8%
Previous 0.93%
Shares
5 transactions
Others Institutions Holding INCY
# of Institutions
694Shares Held
193MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.01 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.39 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.31 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$971 Million0.55% of portfolio
-
State Street Corp Boston, MA10MShares$655 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14.5B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...